Home/Filings/4/0001213900-25-122641
4//SEC Filing

HSU ERIC C 4

Accession 0001213900-25-122641

CIK 0001728328other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 12:16 PM ET

Size

5.5 KB

Accession

0001213900-25-122641

Insider Transaction Report

Form 4
Period: 2025-12-15
HSU ERIC C
Sr VP, Pre-Clinical Res/Dev
Transactions
  • Expiration (Short)

    Employee Stock Option (Expiration)

    2025-12-15705,280 total
    Exercise: $1397.97From: 2020-12-16Exp: 2025-12-15Common shares (70 underlying)
Footnotes (1)
  • [F1]Converted from the Canadian dollar exercise price of C$1,925.00 using an exchange rate of C$1.3770 = $US1.00

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001817867

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 12:16 PM ET
Size
5.5 KB